Indivior Pharmaceuticals, Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
INDV$36.28+2.6%Stored close · as of Nov 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
The following table contains information regarding the Company's principal physical properties.
| Location | Tenure | Principal use |
|---|---|---|
| Richmond, Virginia | Leased | Office space |
| Hull, England | Owned(1) | Fine Chemical Plant manufacturing facility |
| Hull, England | Owned(2) | Chapleo Building research and development facility |
| Raleigh, North Carolina | Owned | Manufacturing and warehousing |
| Fort Collins, Colorado | Leased(2) | Office space and research facility |
| Slough, England | Leased(2) | Office space |
(1)The Hull, England property is leased for 150 years and accounted for as owned.
(2)The Company is actively marketing these properties in connection with the optimization of its operations.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.